−£1,714
−125%vs Feb 2024Active14658166Private limited companyStockport
NK PHARM LIMITED
Significant control: Nabeel Adam Khan (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Nk Pharm Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Nk Pharm Limited sell?
Registered activity: Manufacture of basic pharmaceutical products (SIC 21100). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
NK PHARM LIMITED is an active private limited company (company number 14658166) incorporated on 13 February 2023, registered in Stockport. Its registered activity is manufacture of basic pharmaceutical products (SIC 21100). Latest abridged accounts cover the period ending 28 February 2025, showing net assets of −£1,714 and cash of £28k, with 1 employee on average. As abridged accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets fell 125% on the prior period (£6,972).
Peer position · net assets
By net assets it sits in the bottom quarter of 661 comparable companies in the UK (median £265, upper quartile £89k).
02
Ownership and control
- Mr Nabeel Adam Khan
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 13 February 20233 yrs ago
- Next accounts due
- 28 November 2026in 35 days
- Confirmation statement due
- 27 February 2027in 126 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 21100
- Manufacture of basic pharmaceutical products
- Accounts type
- Unaudited Abridged
- Size band
- MicroCompanies Act thresholds
05
Financials
£28k
+8%vs Feb 2024Not disclosed
1
No changevs Feb 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 28 February 2025 | −£1,714 | £28k | — | £31k | — | — | 1 |
| 28 February 2024 | £6,972 | £26k | — | £20k | — | — | 1 |
Current ratio0.92Current assets ÷ creditors within one year
Cash per employee£28kCash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets below zeroNet assets £-1,714 at 28 February 2025
- Net assets down 25% or more on the prior period-124.6% vs prior period
- Current assets below creditors within one yearCurrent ratio 0.92
- Incorporated two to five years agoIncorporated 13 February 2023
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 126 days
- Next accounts duein 35 days
- Accounts period endNet liabilities £1,714 · abridged accounts
- Accounts period endNet assets £6,972 · abridged accounts
- Incorporated
08
Similar companies in Manchester
- TIBTECH LIMITEDAltrincham · inc. Feb 2023
- IOVANCE BIOTHERAPEUTICS UK LTDAltrincham · inc. Jan 2023
- INSITUGEN (UK) LIMITEDCheadle · inc. Mar 2023
- THERAGENIX LTDManchester · inc. Dec 2022
- BP MED LIMITEDManchester · inc. Nov 2022
- COMANCHE BIOPHARMA (UK) LIMITEDAltrincham · inc. Sept 2022
All companies incorporated on 13 February 2023 · in Feb 2023.
09
Reminders for NK PHARM LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.